A. OĞUL Et Al. , "Clinical Significance of PRAME and PDL-1 Expression in Colon Cancer," 3. Ulusal İmmunoterapi ve Onkoloji Kongresi , Turkey, 2019
OĞUL, A. Et Al. 2019. Clinical Significance of PRAME and PDL-1 Expression in Colon Cancer. 3. Ulusal İmmunoterapi ve Onkoloji Kongresi , (Turkey).
OĞUL, A., PAYDAŞ, S., DORAN, F., EREN ATEŞ, K., TOHUMCUOĞLU, M., BÜYÜKŞİMŞEK, M., ... YETİŞİR, A. E.(2019). Clinical Significance of PRAME and PDL-1 Expression in Colon Cancer . 3. Ulusal İmmunoterapi ve Onkoloji Kongresi, Turkey
OĞUL, ALİ Et Al. "Clinical Significance of PRAME and PDL-1 Expression in Colon Cancer," 3. Ulusal İmmunoterapi ve Onkoloji Kongresi, Turkey, 2019
OĞUL, ALİ Et Al. "Clinical Significance of PRAME and PDL-1 Expression in Colon Cancer." 3. Ulusal İmmunoterapi ve Onkoloji Kongresi , Turkey, 2019
OĞUL, A. Et Al. (2019) . "Clinical Significance of PRAME and PDL-1 Expression in Colon Cancer." 3. Ulusal İmmunoterapi ve Onkoloji Kongresi , Turkey.
@conferencepaper{conferencepaper, author={ALİ OĞUL Et Al. }, title={Clinical Significance of PRAME and PDL-1 Expression in Colon Cancer}, congress name={3. Ulusal İmmunoterapi ve Onkoloji Kongresi}, city={}, country={Turkey}, year={2019}}